Comparison of stent placement and colostomy as palliative treatment for inoperable malignant colorectal obstruction

Tomiki, Yuichi; Watanabe, Tomoo; Ishibiki, Yoshiro; Tanaka, Masanobu; Suda, Shoko; Yamamoto, Toru; Sakamoto, Kazuhiro; Kamano, Toshiki

doi:10.1007/bf02637122

Cited by 10 publications

(36 citation statements)

References 11 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Several studies reported that the median patency duration of palliative SEMS was 106 days (range 68–288 days) 7,16,26,30 . The discrepancies of stent patency might be due to characteristics of the patients, underlying malignancies or stent types 7,8 .…”

Section: Discussionsupporting

confidence: 69%

Clinical outcomes of palliative self‐expanding metallic stents in patients with malignant colorectal obstruction

Kim

Han

Hong

et al. 2012

J of Digest Diseases

View full text Add to dashboard Cite

OBJECTIVE:Self-expanding metallic stents (SEMS) are useful palliative option and a bridge to surgery in malignant colorectal obstruction. The aim of this study was to evaluate the clinical outcomes of SEMS to palliate colorectal malignant obstruction. METHODS:Malignant colorectal obstructive patients who underwent SEMS insertion at the National Cancer Center, Korea from January 2004 to June 2008 were enrolled in the study. Patients' clinical characteristics, outcomes and complications for palliative SEMS insertion were retrospectively analyzed. RESULTS:A total of 54 patients were enrolled in the palliative SEMS group and 48 patients with obstructive CRC were included in the SEMS as the bridge to surgery group. Obstruction of the left colon occurred in 52 patients of the palliative SEMS group and all patients in SEMS as bridge to surgery group. For primary SEMS insertion, the technical success (TS) rate was 87.0% and the clinical success (CS) rate 89.4%, while the rates of early and late complications were 24.1% and 23.4%, respectively. There was no procedure-related mortality. Stent migration rate was higher in the cases treated with small diameter and covered type of stents. Median time to reobstruction and migration were 85 and 101 days, respectively. TS and CS rates for SEMS reinsertion were comparable to those for primary SEMS insertion. CONCLUSIONS:Palliative SEMS are effective and favorable procedures for malignant colorectal obstruction but with some complications. Stent migration is associated with covered type and small diameter stents while other factors including length of stent and chemotherapy do not affect stent complications in the present study.

show abstract

Section: Discussionsupporting

confidence: 69%

Clinical outcomes of palliative self‐expanding metallic stents in patients with malignant colorectal obstruction

Kim

Han

Hong

et al. 2012

J of Digest Diseases

View full text Add to dashboard Cite

show abstract

“…Alternatively, they can also be used as a 'bridge to surgery' by facilitating colonic decompression and adequate patient preparation prior to elective surgery. [7][8][9][10] There are few previously published series of patients undergoing colorectal stenting for malignant obstruction in Australia. 11,12 We describe our experience of colorectal stenting in the management of patients who presented with malignant obstructive symptoms over an 8-year period at a tertiary referral centre in South Australia.…”

Section: Introductionmentioning

confidence: 99%

Colorectal stenting for malignant obstruction: an 8‐year clinical experience

Chouhan

Wong

Maharaj

et al. 2012

ANZ Journal of Surgery

View full text Add to dashboard Cite

show abstract

“…Arch Surg. 2011;146 (10):1157-1162 O NE-QUARTER OF PATIENTS with colorectal cancer (CRC) develop bowel obstruction. 1 In approximately 30% of these individuals, curative resection is not feasible because of advanced disease and comorbidities.…”

mentioning

confidence: 99%

“…[3][4][5][6][7] Once placed, a SEMS relieves obstruction, avoiding colostomy, with improved quality of life until death in approximately 85% of patients. 3,[7][8][9][10] However, approximately 25% of patients with this stent develop complications, such as perforation, occlusion, and migration, which are usually early events. 3,4,6 The endoscopist's experience, tumor location, stricture predilation, and stent characteristics are closely related to the development of early complications.…”

mentioning

confidence: 99%

Endoscopic Palliation in Patients With Incurable Malignant Colorectal Obstruction by Means of Self-expanding Metal Stent

et al. 2011

View full text Add to dashboard Cite

To evaluate the short-and long-term efficacy of self-expanding metal stents (SEMSs) in patients with colorectal obstruction and incurable cancer and the related factors that affect outcomes. Design: Retrospective analysis of SEMS placement for incurable colorectal obstruction in a 3-year period. Setting: Five tertiary care endoscopic centers. Patients and Intervention: Consecutive patients (N=201) undergoing stenting for incurable malignant obstruction. Main Outcome Measurements: Clinical and technical success of stenting, complications rate, and factors affecting outcomes. Results: Technical success was achieved in 184 of 201 patients (91.5%) and clinical success occurred in 165 of 184 patients (89.7%; 82.1% of 201 patients). Technical

show abstract

Comparison of stent placement and colostomy as palliative treatment for inoperable malignant colorectal obstruction

Cited by 10 publications

References 11 publications

Clinical outcomes of palliative self‐expanding metallic stents in patients with malignant colorectal obstruction

Clinical outcomes of palliative self‐expanding metallic stents in patients with malignant colorectal obstruction

Colorectal stenting for malignant obstruction: an 8‐year clinical experience

Endoscopic Palliation in Patients With Incurable Malignant Colorectal Obstruction by Means of Self-expanding Metal Stent

Contact Info

Product

Resources

About